Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DORIA

Showing results (271-280 of 667) with videos related to

Pageof 67
Sort By:
Nature Communications|October 10, 2018
Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturationErik L Johnson, Nicole A Doria-Rose, Jason Gorman, et al.
Annals of the Rheumatic Diseases|September 25, 2008
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up studyA Ruffatti, T Del Ross, M Ciprian, et al.
Lupus|May 22, 2018
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onsetG D Sebastiani, I Prevete, A Iuliano, et al.
Journal of Autoimmunity|June 13, 2020
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patientsM Zen, E Fuzzi, D Astorri, et al.
Structure (London, England : 1993)|April 12, 2022
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding siteTongqing Zhou, Lei Chen, Jason Gorman, et al.
Journal of Virology|March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved ImmunogenicityGwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Mabs|October 30, 2020
Removal of variable domain <i>N</i>-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodiesGwo-Yu Chuang, Mangaiarkarasi Asokan, Vera B Ivleva, et al.
Vaccines|November 26, 2025
Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization BreadthCamila T França, Sergei Pletnev, Bharat Madan, et al.
Mabs|June 22, 2023
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domainYoung D Kwon, Amarendra Pegu, Eun Sung Yang, et al.
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Pageof 67

Showing results (271-280 of 667) with videos related to

Sort By:
Pageof 67
Nature Communications|October 10, 2018
Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturationErik L Johnson, Nicole A Doria-Rose, Jason Gorman, et al.
Annals of the Rheumatic Diseases|September 25, 2008
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up studyA Ruffatti, T Del Ross, M Ciprian, et al.
Lupus|May 22, 2018
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onsetG D Sebastiani, I Prevete, A Iuliano, et al.
Journal of Autoimmunity|June 13, 2020
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patientsM Zen, E Fuzzi, D Astorri, et al.
Structure (London, England : 1993)|April 12, 2022
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding siteTongqing Zhou, Lei Chen, Jason Gorman, et al.
Journal of Virology|March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved ImmunogenicityGwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Mabs|October 30, 2020
Removal of variable domain <i>N</i>-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodiesGwo-Yu Chuang, Mangaiarkarasi Asokan, Vera B Ivleva, et al.
Vaccines|November 26, 2025
Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization BreadthCamila T França, Sergei Pletnev, Bharat Madan, et al.
Mabs|June 22, 2023
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domainYoung D Kwon, Amarendra Pegu, Eun Sung Yang, et al.
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Pageof 67